[Why does nitroglycerin tolerance appear?]

L Włodek1, M Sokołowska

  • 1Instytut Biochemii Lekarskiej Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.

Postepy Higieny I Medycyny Doswiadczalnej
|January 25, 2002
PubMed

Insights

Organic nitrates like nitroglycerin effectively treat coronary artery disease but cause tolerance. This tolerance stems from altered vascular smooth muscle bioactivation or physiological responses to increased nitric oxide production.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Biochemistry

Context:

  • Organic nitrates, including nitroglycerin, are vital for managing acute coronary artery disease.
  • Hemodynamic tolerance significantly limits the long-term efficacy of these essential medications.
  • Understanding tolerance mechanisms is crucial for optimizing nitrate therapy.

Purpose:

  • To review and categorize the primary mechanisms underlying the development of hemodynamic tolerance to organic nitrates.
  • To differentiate between vascular bioactivation changes and physiological responses to nitric oxide.

Summary:

  • Tolerance to organic nitrates involves two main categories of mechanisms.
  • These include alterations in how vascular smooth muscle bioactivates nitrates.
  • They also encompass physiological adaptations in response to increased nitric oxide (NO) signaling.

Impact:

  • Provides a framework for understanding nitrate tolerance in clinical practice.
  • Highlights key pathways that may be targeted for future therapeutic interventions.
  • Aids researchers in focusing on specific mechanisms to overcome drug limitations.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...